메뉴 건너뛰기




Volumn 59, Issue 1, 2014, Pages 46-48

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; CREATININE; HEMOGLOBIN; PEGINTERFERON ALPHA2A; RIBAVIRIN; TELAPREVIR; ANTIVIRUS AGENT; INTERFERON; N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE; OLIGOPEPTIDE; PROLINE; DRUG DERIVATIVE; N (3 AMINO 1 (CYCLOBUTYLMETHYL) 2,3 DIOXOPROPYL) 3 (2 ((((1,1 DIMETHYLETHYL)AMINO)CARBONYL)AMINO) 3,3 DIMETHYL 1 OXOBUTYL) 6,6 DIMETHYL 3 AZABICYCLO(3.1.0)HEXAN 2 CARBOXAMIDE;

EID: 84894876789     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26602     Document Type: Article
Times cited : (82)

References (6)
  • 4
    • 84870947010 scopus 로고    scopus 로고
    • Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection
    • Flamm SL, Lawitz E, Jacobson I, Bourliere M, Hezode C, Vierling JM, et al. Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection. Clin Gastroenterol Hepatol 2013;11:81-87.
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 81-87
    • Flamm, S.L.1    Lawitz, E.2    Jacobson, I.3    Bourliere, M.4    Hezode, C.5    Vierling, J.M.6
  • 5
    • 84871206253 scopus 로고    scopus 로고
    • Safety and efficacy of telaprevir or boceprevir in combination with peginterferon alfa/ribavirin, in 497 cirrhotic non responders. Week 16 analysis of the French early access program (ANRS CO20-CUPIC) in real-life setting
    • Hézode C, Dorival C; Zoulim F, Larrey DG, Pol S, Cacoub P, Canva V, et al. Safety and efficacy of telaprevir or boceprevir in combination with peginterferon alfa/ribavirin, in 497 cirrhotic non responders. Week 16 analysis of the French early access program (ANRS CO20-CUPIC) in real-life setting. Hepatology 2012;56(suppl):217A.
    • (2012) Hepatology , vol.56 , pp. 217A
    • Hézode, C.1    Dorival, C.2    Zoulim, F.3    Larrey, D.G.4    Pol, S.5    Cacoub, P.6    Canva, V.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.